You have recently taken a type of antidepressant called a monoamine oxidase inhibitor (MAOI)
You have uncontrolled narrow-angle glaucoma (an eye disease)
You are taking Mellaril® (thioridazine)
Before starting Cymbalta, tell your healthcare provider:
About all of your medical conditions, including kidney problems, glaucoma, or diabetes
About your alcohol use
If you are taking nonprescription or prescription medicines, including those for migraine, to address a possible life-threatening condition
If you are taking NSAID pain relievers, aspirin, or blood thinners. Use with Cymbalta may increase bleeding risk
If you are pregnant, plan to become pregnant during therapy, or are breastfeeding an infant
While taking Cymbalta, tell your healthcare provider:
If you have itching, right upper belly pain, dark urine, yellow skin/eyes, or unexplained flu-like symptoms, which may be signs of liver problems. Severe liver problems, sometimes fatal, have been reported
If you have high fever, confusion, and stiff muscles to address a possible life-threatening condition
Before stopping Cymbalta or changing your dose
If you experience dizziness or fainting upon standing, especially when first starting Cymbalta or when increasing the dose. Your healthcare provider may periodically check your blood pressure while you are taking Cymbalta
If you have any questions, talk to your healthcare provider before taking Cymbalta.
Cymbalta is not approved for use in patients under age 18. Remember, only your doctor can decide if Cymbalta is right for you.